Procter & Gamble Stock Forecast for 2023 - 2025 - 2030
Updated on 02/01/2023
Procter & Gamble Stock Forecast and Price Target
Based on the current earnings figures, this year's price targets for Procter & Gamble were recently set by twelve distinguished experts, with an average mark of $155.50. If it reached this goal, it would represent a potential upside of approximately 9.21% from the previous closing price in January, 2023. The high end is $170.00, and the low is $126.00. If you are interested in PG stock, you should also look at its competitors.
9.21% Upside
Procter & Gamble Fair Value Forecast for 2023 - 2025 - 2030
Procter & Gamble's Price has grown In the last three years, rising from $107.21 to $142.32 – a growth of 32.74%. In the next year, analysts believe that Fair Value will reach $148.49 – an increase of 4.33%. For the next eight years, experts predict that Procter & Gamble's Fair Value will grow at a rate of 56.17%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| JNJ Stock Forecast | Johnson & Johnson | Outperform |
11
|
$163.42 | Buy/Sell | $181.05 | 10.45% |
| ABBV Stock Forecast | AbbVie | Outperform |
10
|
$147.74 | Buy/Sell | $162.12 | 11.68% |
| COST Stock Forecast | Costco Wholesale Corp | Outperform |
13
|
$511.23 | Buy/Sell | $550.07 | 7.09% |
| ABT Stock Forecast | Abbott Laboratories | Outperform |
10
|
$110.55 | Buy/Sell | $116.63 | 13.07% |
| MO Stock Forecast | Altria Group | Hold |
4
|
$45.03 | Buy/Sell | $49.25 | 9.93% |
Procter & Gamble Revenue Forecast for 2023 - 2025 - 2030
Procter & Gamble's Revenue has grown In the last three years, rising from $67.68B to $80187.00T – a growth of 118472508.00%. According to the 20 analysts polled, in the next year, Procter & Gamble's Revenue will fall by 100.00%, reaching $82.95B. By 2030, professionals believe that Procter & Gamble's Revenue will have decreased by 100.00%, falling to $106.73B.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| GSK Stock Forecast | GSK | Hold |
16
|
£1.42k | Buy/Sell | £16.95 | -98.87% |
| KER Stock Forecast | Kering | Outperform |
18
|
527.60€ | Buy/Sell | 621.06€ | 17.51% |
| CL Stock Forecast | Colgate-Palmolive Co | Outperform |
18
|
$74.53 | Buy/Sell | $81.35 | 10.02% |
.jpg)
Procter & Gamble Dividend per Share Forecast for 2023 - 2025 - 2030
Procter & Gamble's Dividend per Share has seen impressive growth In the last three years, rising from $2.90 to $3.65 – a growth of 25.86%. In the next year, analysts believe that Dividend per Share will reach $3.71 – an increase of 1.64%. For the next eight years, the forecast is for Dividend per Share to grow by 61.64%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| BAYN Stock Forecast | Bayer | Outperform |
7
|
57.00€ | Buy/Sell | 74.54€ | 32.46% |
| GIS Stock Forecast | General Mills | Hold |
16
|
$78.36 | Buy/Sell | $81.79 | 4.65% |
| ALC Stock Forecast | Alcon | Outperform |
15
|
CHF66.18 | Buy/Sell | CHF0.00 | 30.51% |
Procter & Gamble Free Cash Flow Forecast for 2023 - 2025 - 2030
In the last three years, Procter & Gamble's Free Cash Flow has grown, moving from $11.90B to $16808.00T – an increase of 141302941.98%. In the following year, 8 experts forecast Procter & Gamble's Free Cash Flow will decrease by 100.00%, to $15.74B. In 2030, professionals predict that Procter & Gamble's Free Cash Flow will decrease by 100.00%, to $21.42B.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| BN Stock Forecast | Danone | Hold |
18
|
49.65€ | Buy/Sell | 55.47€ | 11.78% |
| HEN3 Stock Forecast | Henkel AG & Co. KGaA | Hold |
16
|
65.40€ | Buy/Sell | 66.02€ | 1.68% |
| COLO B Stock Forecast | Coloplast A/S | Hold |
18
|
kr848.20 | Buy/Sell | kr1.05k | 21.43% |
Procter & Gamble Net Income Forecast for 2023 - 2025 - 2030
In the last three years, Procter & Gamble's Net Income has grown by 379599592.07%, rising from $3.90B to $14793.00T. According to 18 prominent analysts, Procter & Gamble's Net Income will fall by 100.00% in the next year, reaching $15.66B. By 2030, professionals believe that Procter & Gamble's Net Income will decrease by 100.00%, reaching $20.82B – a concerning trend for the company.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| K Stock Forecast | Kellogg | Hold |
13
|
$68.58 | Buy/Sell | $73.45 | 7.90% |
| 4452 Stock Forecast | Kao | Outperform |
18
|
¥5.11k | Buy/Sell | ¥0.00 | 17.53% |
| CHD Stock Forecast | Church & Dwight Co Inc | Hold |
11
|
$80.87 | Buy/Sell | $82.17 | 5.11% |
Procter & Gamble EBITDA Forecast for 2023 - 2025 - 2030
In the last three years, Procter & Gamble's EBITDA has seen an increase, rising from $16.66B to $21241.00T. This represents a growth of 127527517.68%. According to 18 major analysts, Procter & Gamble's EBITDA will fall by 100.00% in the next year, reaching $22.25B. Professionals believe that By 2030, Procter & Gamble's EBITDA will fall to $29.99B– a 100.00% decrease from its current value.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| CPB Stock Forecast | Campbell Soup | Hold |
16
|
$57.01 | Buy/Sell | $52.53 | -7.03% |
| PHIA Stock Forecast | Koninklijke Philips N.V. | Outperform |
18
|
15.33€ | Buy/Sell | 50.07€ | 98.96% |
| CA Stock Forecast | Carrefour | Outperform |
18
|
16.02€ | Buy/Sell | 19.86€ | 20.47% |
Procter & Gamble EBIT Forecast for 2023 - 2025 - 2030
Procter & Gamble's EBIT has seen growth In the last three years, going from $13.83B to $17.81B – a gain of 28.78% In the next year, analysts believe that EBIT will reach $19.19B – an increase of 7.72%. For the next eight years, the forecast is forEBIT to grow by 47.53%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| BIM Stock Forecast | bioMérieux | Outperform |
18
|
96.70€ | Buy/Sell | 105.55€ | 11.17% |
| BBWI Stock Forecast | Bath & Body Works | Outperform |
15
|
$46.01 | Buy/Sell | $51.40 | 6.50% |
| 500124 Stock Forecast | Dr. Reddy's Laboratories | Outperform |
18
|
Rp4.27k | Buy/Sell | Rp5.47k | 15.97% |
Procter & Gamble EPS Price Prediction Forecast for 2023 - 2025 - 2030
Procter & Gamble's EPS has grown In the last three years, rising from $4.52 to $6.00 – a growth of 32.74%. In the next year, analysts believe that EPS will reach $6.26 – an increase of 4.33%. For the next eight years, experts predict that Procter & Gamble's EPS will grow at a rate of 56.17%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| A090430 Stock Forecast | Amorepacific | Outperform |
18
|
₩137.50k | Buy/Sell | ₩269.69k | 52.36% |
| KIMBER A Stock Forecast | Kimberly-Clark de México, S. ... | Outperform |
18
|
Mex$35.30 | Buy/Sell | Mex$40.00 | -0.85% |
| HYPE3 Stock Forecast | Hypera | Outperform |
16
|
R$46.69 | Buy/Sell | R$44.01 | -6.83% |
Site Navigation
.jpg)